TNF and metabolic dysfunction-associated steatotic liver disease: Inflammatory events in adipose tissue have been shown to drive NAFLD pathogenesis [4], and our results indicated that KSS may target key proinflammatory cytokines and receptors (TLR, TNF, NF-kappa B) to prevent NAFLD progression.